Navigation Links
Increased Risk For Venous Thrombosis In Cancer Patients

Based on findings of a recent study researchers say , cancer patients have a seven-fold increased risk for venous thrombosis, // or blood clots in the legs or lungs.

Researchers studied 3,220 patients, ages 18 to 70, who had a blood clot in their legs or lungs. They evaluated different tumor sites, the presence of distant metastases, and carrier status of gene mutations. Patients underwent anticoagulant (anti-clotting) therapy, and then a blood sample was taken. DNA was isolated to determine gene mutations, factor V Leiden and prothrombin 20210A, both linked to thrombosis.

It was found that the overall risk of venous thrombosis was increased by seven-fold in patients with cancer vs. persons without cancer and patients with hematological (blood-related) malignancies had a 28-fold increased risk of venous thrombosis, followed by those with lung cancer and gastrointestinal cancer.

In the first few months after the diagnosis of cancer, the risk of venous thrombosis was highest (53-times greater risk). Patients with cancer with distant metastases had a higher risk compared to patients without distant matastases (20-times greater risk). Cancer patients who also carry the V Leiden mutation had a 12-fold increased risk vs. individuals without cancer and factor V Leiden. Similar results were indirectly calculated for the prothrombin 20210A mutation in patients with cancer.

Thus researchers say for patients with cancer who have an increased risk to develop venous thrombosis, prophylactic anticoagulant therapy may be more cost effective than screening for the factors.
'"/>




Page: 1

Related medicine news :

1. Use of Cellular Phones associated with Increased risk of Brain Tumors
2. Increased Heart Attack Risk From Celebrex,Vioxx
3. Allergy Risk Increased by Kerosene Use
4. Fewer teeth & Increased Ischemic Stroke risk
5. Young Smokers at Increased Risk Of Developing a Heart Attack
6. Women With Diabetes At Increased Risk Of Developing Cognitive Impairment
7. Asbestos Exposure Associated With An Increased Risk For Autoimmune Disease
8. Schizophrenics On Medication At An Increased Risk For Developing Diabetes
9. Diabetics Found To Be At An Increased Risk Of Developing Cancer
10. Increased risk of common infections in patients suffering from diabetes
11. Infertility Associated With Increased Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2017)... , ... March 27, 2017 , ... ... Conventional sodium testing methods are complicated and require expert user knowledge. In a ... analytical method dedicated to the simplified, yet highly accurate, determination of sodium. , ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... 167%,(1) with opioids alone responsible for over 33,000 of the 52,404 drug-related deaths ... Assembly Bill (AB) 1512, which proposes a tax on prescription opioids to fund ...
(Date:3/25/2017)... , ... March 25, 2017 , ... Getting earned media ... public relations partner. , All through the year, Garden Media aims to provide ... working with key influencers and pitching client’s key messages to gain coveted ...
(Date:3/24/2017)... ... 24, 2017 , ... Mediaplanet today announces distribution of its ... obstacles facing infection prevention and offer strategies for the health care community to ... , The print component of “Fighting Infection” is distributed within the Friday, March ...
(Date:3/24/2017)... Dallas, Texas (PRWEB) , ... March 24, 2017 , ... ... Budget Office score is invalid because it does not obey the rules Congress has ... million full-time equivalent jobs, which the GOP reform would restore. Yet, it estimates a ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... FRANCISCO , March 27, 2017  Twist Bioscience, ... DNA synthesis, today announced that it raised an additional ... total of $166 million. "It is ... we expand our reach and continue to deliver industry-leading ... multiple market segments," commented Emily M. Leproust, Ph.D., CEO ...
(Date:3/27/2017)... , March 27, 2017  PhaseRx, Inc. (NASDAQ: ... life-threatening inherited liver diseases in children, today reported ... year ended December 31, 2016 and provided an ... "PhaseRx continued to make progress during the fourth ... results from our non-human primate safety study, and with ...
(Date:3/27/2017)... 2017 Invivotek, LLC, a Genesis Biotechnology Group ... pharmacology contract research organization (CRO), announced the completion ... expanded preclinical research facility in Hamilton, New ... renewable energy source to reduce costs and lessen the ... Genesis Solar Farm follows Invivotek,s recent expansion from a ...
Breaking Medicine Technology: